» Articles » PMID: 27873508

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2016 Nov 23
PMID 27873508
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: False-positive (FP) results of fecal immunochemical tests (FITs) conducted in colorectal cancer (CRC) screening could lead to performing unnecessary colonoscopies. Hemorrhoids are a possible cause of FP FIT results; however, studies on this topic are extremely rare. We investigated whether hemorrhoids are associated with FP FIT results.

Materials And Methods: A retrospective study was conducted at a university hospital in Korea from June 2013 to May 2015. Of the 34547 individuals who underwent FITs, 3946 aged ≥50 years who underwent colonoscopies were analyzed. Logistic regression analysis was performed to determine factors associated with FP FIT results.

Results: Among 3946 participants, 704 (17.8%) showed positive FIT results and 1303 (33.0%) had hemorrhoids. Of the 704 participants with positive FIT results, 165 had advanced colorectal neoplasia (ACRN) and 539 had no ACRN (FP results). Of the 1303 participants with hemorrhoids, 291 showed FP results, of whom 81 showed FP results because of hemorrhoids only. Participants with hemorrhoids had a higher rate of FP results than those without hemorrhoids (291/1176, 24.7% vs. 248/2361, 10.5%; p<0.001). Additionally, the participants with hemorrhoids as the only abnormality had a higher rate of FP results than those experiencing no such abnormalities (81/531, 15.3% vs. 38/1173, 3.2%; p<0.001). In multivariate analysis, the presence of hemorrhoids was identified as an independent predictor of FP results (adjusted odds ratio, 2.76; 95% confidence interval, 2.24-3.40; p<0.001).

Conclusion: Hemorrhoids are significantly associated with FP FIT results. Their presence seemed to be a non-negligible contributor of FP results in FIT-based CRC screening programs.

Citing Articles

Changes in faecal haemoglobin values over sequential rounds of faecal immunochemical tests (FIT) in a surveillance population.

Mortell G, Wooldrage K, Murphy G, Cross A BMJ Open Gastroenterol. 2025; 12(1).

PMID: 39933781 PMC: 11843008. DOI: 10.1136/bmjgast-2024-001651.


Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids.

Ebner D, Rushlow D, Mou J, Porter K, Finney Rutten L, Limburg P Mayo Clin Proc Innov Qual Outcomes. 2023; 7(4):320-326.

PMID: 37502338 PMC: 10371761. DOI: 10.1016/j.mayocpiqo.2023.06.003.


Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer-Experience from a Hospital in Central Taiwan.

Yang P, Yang I, Chiang T, Tsai C, Yang Y, Lin I Medicina (Kaunas). 2023; 59(4).

PMID: 37109638 PMC: 10146924. DOI: 10.3390/medicina59040680.


A positive faecal immunochemical test result and its association with the incidence of rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis: an analysis of one-million national colorectal cancer screening programme results.

Noh C, Lee E, Park B, Ahn S BMC Med. 2022; 20(1):226.

PMID: 35786411 PMC: 9251919. DOI: 10.1186/s12916-022-02416-y.


Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients.

Johnstone M, Miller G, Pang G, Burton P, Kourounis G, Winter J Ann Clin Biochem. 2022; 59(4):277-287.

PMID: 35044264 PMC: 9280700. DOI: 10.1177/00045632221076771.


References
1.
Lee H, Jeon S . Is Retroflexion Helpful in Detecting Adenomas in the Right Colon?: A Single Center Interim Analysis. Intest Res. 2015; 13(4):326-31. PMC: 4641859. DOI: 10.5217/ir.2015.13.4.326. View

2.
Kim Y, Noh R, Cho S, Park S, Jeon S, Shin H . Inhibitory effect of metformin therapy on the incidence of colorectal advanced adenomas in patients with diabetes. Intest Res. 2015; 13(2):145-52. PMC: 4414756. DOI: 10.5217/ir.2015.13.2.145. View

3.
Lee T, Hull M, Rajasekhar P, Clifford G, Ritchie M, James P . Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?. Digestion. 2012; 85(4):278-81. DOI: 10.1159/000334372. View

4.
Lieberman D, Rex D, Winawer S, Giardiello F, Johnson D, Levin T . Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143(3):844-857. DOI: 10.1053/j.gastro.2012.06.001. View

5.
Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E . A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007; 146(4):244-55. DOI: 10.7326/0003-4819-146-4-200702200-00003. View